| Structure |
Chemical Name |
CAS |
MF |
 |
Cabozantinib impurity 39 |
|
|
 |
Butyphthalide impurity 27 |
33704-16-4 |
C12H12O5 |
 |
Carbidopa Impurity 2 |
1361017-74-4 |
C11H16N2O4 |
 |
Butyphthalide impurity 42 |
952412-79-2 |
C10H12O3 |
 |
Imatinib Impurity 10 |
|
|
 |
(1S,2R)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide |
|
|
 |
Avatrombopag Impurity 54 |
|
|
 |
Esomeprazole Impurity 43 |
2826359-93-5 |
|
 |
dextroMethorphanone |
|
|
 |
Desacetyl CefathiaMidine |
958001-61-1 |
C17H26N4O5S2 |
 |
Cefuroxime Impurity 33 |
929531-94-2 |
C16H16N4O9S |
 |
IRAS vials are low alkaline and meet the pharmacopoeia standards of various countries |
|
|
 |
Lincomycin sulfoxide Impurity 5 |
|
|
 |
P-トルエンスルホン酸2,6-ジアミノ-4-ピリミジニル3-オキシド |
75105-16-7 |
C11H12N4O4S |
 |
YXSRVOWUJUXDLJ-UHFFFAOYSA-N |
1618107-97-3 |
C18H18FNO2S |
 |
22,23-Didehydro SelaMectin |
165108-09-8 |
C43H61NO11 |
 |
Selexipag Impurity 6 |
|
|
 |
Acetaminophen Impurity B |
98966-17-7 |
C16H16N2O4 |
 |
Ticagrelor Impurity 118 |
|
|
 |
Palonosetron Impurity 9 |
2216755-75-6 |
C18H24N2O |
 |
オルト-メトプロロール |
163685-38-9 |
C15H25NO3 |
 |
Loratadine IMpurity C |
|
C22H23ClN2O2 |
 |
Crisaborole Impurity 4 |
|
|
 |
Imatinib Impurity 5 |
|
|
 |
Empagliflozin Impurity 83 |
|
|
 |
12-O-メチルクラリスロマイシン |
128940-83-0 |
C39H71NO13 |
メタノン](/CAS/GIF/105356-90-9.gif) |
[4-(4-アミノ-7-ヒドロキシ-6-メトキシ-2-キナゾリニル)-1-ピペラジニル](テトラヒドロ-2-フラニル)メタノン |
105356-90-9 |
C18H23N5O4 |
 |
Fasudil iMpurity D |
|
|
 |
Δ3-7-ACT |
|
|
 |
Aprepitant impurity 1 |
|
|
 |
1,4,8,11-tetraazacyclotetradecane sodium chelation |
|
|
 |
2-(2-フリルメチルアミノ)-4-ヒドロキシ-5-スルファモイル安息香酸 |
133989-65-8 |
C12H12N2O6S |
 |
N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide |
1447715-45-8 |
C19H31NO5 |
 |
Cabozantinib impurity 35 |
1905820-17-8 |
C17H14F2N2O2 |
 |
(2R,3R,4R,5R)-2-(4-amino-2-oxo |
1415316-72-1 |
C12H16N4O7 |
 |
Rabeprazole Impurity 21 |
|
|
 |
Revefenacin Impurity 21 |
|
|
 |
Metoprolol IMpurity T |
|
C15H25NO3 |
 |
Paris polyphylla |
|
|
 |
4,4'-(2-ピリジニルメチレン)ビスフェノール |
603-41-8 |
C18H15NO2 |
 |
Nitrendipine iMpurity G |
|
|
 |
3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
![L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester](/CAS/20210111/GIF/1119226-56-0.gif) |
L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]tridecyl ester |
1119226-56-0 |
C30H55NO5 |
 |
Bisoprolol Impurity 51 |
|
|
 |
Tenofovir Impurity W |
1244022-55-6 |
C15H24N5O8P |
 |
Ropivacaine Impurity 42 |
|
|
 |
Febuxostat Impurity 56 |
|
|
 |
Pitavastatin Impurity 23 |
1467166-39-7 |
C28H28FNO4 |
![(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide](/) |
(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide |
|
|
 |
Nicergoline Impurity 01 |
|
|
 |
Azilsartan Impurity |
1586011-04-2 |
C26H25N3O4 |
 |
(S)-4-(4-Nitrobenzyl)-2-oxazolidinone |
139264-55-4 |
C10H10N2O4 |
![4-(6-((6-ブロモ-8-シクロペンチル-5-メチル-7-オキソ-7,8-ジヒドロピリド[2,3-D]ピリミジン-2-イル)アミノ)ピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル](/StructureFile/ChemBookStructure22/GIF/CB61010565.gif) |
4-(6-((6-ブロモ-8-シクロペンチル-5-メチル-7-オキソ-7,8-ジヒドロピリド[2,3-D]ピリミジン-2-イル)アミノ)ピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
571188-82-4 |
C27H34BrN7O3 |
![5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate](/CAS/20200331/GIF/949155-13-9.gif) |
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
 |
(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
1428118-12-0 |
C37H43FN2O5 |
 |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
 |
Ticagrelor IMpurity E |
1402150-34-8 |
C26H30F2N6O5S |
 |
(1'S,3'S,4'S)-Entecavir IsoMer |
1367369-80-9 |
C12H15N5O3 |
 |
(Z)-N-(2-nitrovinyl)acetaMide |
1238305-24-2 |
C4H6N2O3 |
 |
Spectinomycin Impurity E |
|
|
 |
Cabozantinib impurity 31 |
|
|
 |
Tofacitinib Impurity 82 |
|
|
 |
Esomeprazole Impurity 26 |
704910-88-3 |
C15H15N3OS |
 |
Sunitinib iMpurity E |
|
|
 |
4-Chlor-3-nitro-5-sulfobenzoesure |
130262-91-8 |
C7H4ClNO7S |
 |
Butyphthalide impurity 47 |
|
|
 |
Tazobactam Impurity 10 |
|
|
 |
Oseltamivir Impurity 3 |
|
|
 |
Apixaban IMpurity(BMS-778960-01) |
|
|
 |
Carbetocin Impurity 1 |
|
|
 |
Rivaroxaban Impurity 65 |
|
|
 |
rac-Clopidogrel Carboxylic Acid Hydrochloride |
1015247-88-7 |
C15H15Cl2NO2S |
![(R)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone](/) |
(R)-(2-(6-chloro-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone |
|
|
 |
Lenacapavir impurity |
3025145-48-3 |
C41H36ClF10N7O5S2 |
 |
Cilostazol Impurity I |
|
|
 |
Canagliflozin Impurity 54 |
|
|
 |
Cefuroxime Impurity 9 |
2165460-37-5 |
C8H10N2O4S |
 |
Peramivir Impurity 45 |
|
|
 |
(S)-ズロキセチンフタルアミド |
199191-67-8 |
C26H23NO4S |
 |
Cefazolin Impurity L |
|
|
![N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide](/CAS/20210111/GIF/1628530-41-5.gif) |
N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluoro-3-hydroxyphenyl)-1,1-cyclopropanedicarboxamide |
1628530-41-5 |
C28H24FN3O6 |
 |
Erlotinib Impurity 20 |
|
|
 |
(3R)-2,3-Dihydro-3-(2-propyn-1-ylaMino)-1H-inden-1-one |
1312077-05-6 |
C12H11NO |
 |
3-Cyano-4-isobutoxybenzoic acid |
528607-60-5 |
C12H13NO3 |
 |
(1-ジアゾ-2-オキソプロピル)ホスホン酸ジメチル |
90965-06-3 |
C5H9N2O4P |
 |
Febuxostat Impurity 15 Complete Set |
|
|
 |
Celecoxib Impurity 19 |
|
C17H14F3N3O2S |
 |
Flucloxacillin Impurity A |
|
|
 |
Peramivir Deacetyl Impurity |
|
|
 |
Afatinib Impurity I |
|
|
 |
Moxidectin |
119718-45-5 |
C37H53NO8 |
![5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate](/CAS/20150408/GIF/1056459-37-0.gif) |
5-(5-chloro-1-(2-fluorophenyl)-2-oxopentyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl acetate |
1056459-37-0 |
C20H21ClFNO3S |
 |
Retigabine Dihydrochloride Impurity |
1432063-93-8 |
C16H19ClFN3O2 |
 |
3β-トシルオキシ-5α-アンドロスタン-17-オン |
10429-07-9 |
C26H36O4S |
 |
Erlotinib Impurity 19 |
|
|
 |
Parecoxib Impurity Q |
1373038-58-4 |
C16H14N2O3S |
 |
Dapagliflozin Impurity 4 |
960404-50-6 |
|
 |
Bosutinib Impurity 8 |
|
|
 |
tirofiban |
464175-13-1 |
C9H18ClN |
 |
Cefaclor EP IMpurity |
|
|